✦ LIBER ✦

Continuous infusion of interleukin-2 in children with refractory malignancies

✍ Scribed by Raul C. Ribeiro; Donna Rill; Paula K. Roberson; Wayne L. Furman; Charles B. Pratt; Malcolm Brenner; William M. Crist; Ching-Hon Pui

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 481 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930715)72:2<623::aid-cncr2820720248>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous infusion of recombinant inter

Continuous infusion of recombinant interleukin-2 and lymphokine-activated killer cells in refractory malignancies

✍ Christiansen, Neal P. ;Kennedy, B. J. ;Ochoa, Augusto C. ;Skubitz, Keith M. ;Bac 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

Continuous infusion of methotrexate in c

Continuous infusion of methotrexate in children with acute leukemia

✍ Isaac Djerassi; Sidney Farber; Esshagh Abir; William Neikirk 📂 Article 📅 1967 🏛 John Wiley and Sons 🌐 English ⚖ 732 KB

Evaluation of interleukin-2 administered

Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma

✍ Sewa S. Legha; Mary Ann Gianan; Carl Plager; Omar E. Eton; Nicholas E. J. Papado 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

## BACKGROUND. Interleukin-2 (IL-2) has been used widely in the treatment of advanced melanoma, most often using a high dose bolus schedule of administration. We have evaluated the antitumor activity and toxicity of IL-2 when administered by a continuous infusion schedule in patients with metastat

Biologic and clinical effects of continu

Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer

✍ Andrea Ardizzoni; Editta Baldini; Carlo Mereu; Anna Verna; Gabriella L. Mariani; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

Central venous device-related infection

Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2

✍ Michael E. Eastman; Masoud Khorsand; Dennis G. Maki; Eliot C. Williams; KyungMan 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Phase I trial of subcutaneous interleuki

Phase I trial of subcutaneous interleukin-1α in children with malignant solid tumors

✍ Furman, Wayne L.; Luo, Xiaolong; Fairclough, Diane; Garrison, Leslie; Marina, Ne 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Interleukin-1 alpha (IL-1 alpha) is myeloprotective in a variety of animal models of cancer chemotherapy and is similarly beneficial in adults treated with carboplatin, 5-fluorouracil, and after autologous bone marrow transplantation. There are no trials of this agent in children. Our purpose was to